STOCK TITAN

If You Invested in DataMeds AI, Inc. (MEDS)

Healthcare · Medical Distribution · NASDAQ
Looking for the current price? See the MEDS quote & overview
$1,000 invested 1 Year Ago
$746
-25.4% price return -70.0% CAGR
-25.4% with dividends reinvested
Bought on Jul 22, 2026 at $3.58 split-adjusted
$1,000 invested 5 Years Ago
$1
-99.9% price return -75.9% CAGR
-99.9% with dividends reinvested
Bought on Oct 20, 2021 at $3270.00 split-adjusted

What $1,000 or $10,000 in MEDS Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Oct 21, 2015
$1,000 $746 -25% $1 -100% $5 -99% $4 -100%
$10,000 $7,458 -25% $8 -100% $51 -99% $36 -100%

Based on real historical closing prices adjusted for stock splits, without dividends, through 2026-10-19. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for MEDS

$1,000 Investment Over Time

MEDS vs S&P 500

Year-by-Year Returns

MEDS annual performance
Year Start Price End Price Annual Return Cumulative
2015 $750.00 $825.00 +10.0% +10.0%
2016 $825.00 $345.00 -58.2% -54.0%
2017 $345.00 $337.50 -2.2% -55.0%
2018 $337.50 $225.00 -33.3% -70.0%
2019 $225.00 $825.00 +266.7% +10.0%
2020 $825.00 $3967.50 +380.9% +429.0%
2021 $3967.50 $1770.00 -55.4% +136.0%
2022 $1770.00 $301.95 -82.9% -59.7%
2023 $301.95 $259.81 -14.0% -65.4%
2024 $259.81 $379.50 +46.1% -49.4%
2026 $379.50 $2.67 -99.3% -99.6%

About DataMeds AI, Inc.

Healthcare · NASDAQ

Market Cap
$0.0B
Current Price
$2.67
EPS
$-1.43
Revenue
$0.0B
Net Margin
-433.9%
View full MEDS overview

Frequently Asked Questions

DataMeds AI, Inc. investment returns

How much would $1,000 invested in DataMeds AI, Inc. be worth today?

If you invested $1,000 in DataMeds AI, Inc. (MEDS) 10 years ago on 2016-10-20, your investment would be worth $5 as of 2026-10-19, a -99.5% price return without dividends, growing at a compounded rate of -41.0% per year (CAGR).

Has DataMeds AI, Inc. outperformed the S&P 500?

Over the past 10 years, MEDS returned -99.5% compared to +258.4% for the S&P 500, underperforming the benchmark by 357.9 percentage points.

What is DataMeds AI, Inc.'s average annual return?

The compound annual growth rate (CAGR) of MEDS’s share price over the past 10 years is -41.0%, without dividends. Individual years vary a great deal, and MEDS’s best recent full year was 2020 (+380.9%) while the worst was 2022 (-82.9%).

For informational and educational purposes only, not investment advice.